Sterile at Speed: Phase I Development in a Post Annex 1 Environment
Securing sterile drug product capacity for early-phase development has never been more challenging. The revised EU GMP Annex 1 guidelines
- Solutions
- By route of deliveryOral, Nasal, Pulmonary & Parenteral
-
-
By route of delivery
-
-
-
Not sure where to start?
Tell us the molecule and the stage.
Every enquiry goes to a formulation scientist.
Start a project →
-
- By stage & servicePre-clinical to market
-
-
By stage & service
-
-
-
Not sure where to start?
Tell us the molecule and the stage.
Every enquiry goes to a formulation scientist.
Start a project →
-
- Platforms & TechnologyOur proprietary toolkit
-
-
Platforms & Technology
-
-
-
Not sure where to start?
Tell us the molecule and the stage.
Every enquiry goes to a formulation scientist.
Start a project →
-
- Complex & Controlled MoleculesSpecialist potency handling
-
-
Complex & Controlled Molecules
-
-
-
Not sure where to start?
Tell us the molecule and the stage.
Every enquiry goes to a formulation scientist.
Start a project →
-
- By route of deliveryOral, Nasal, Pulmonary & Parenteral
- Choose Upperton
-
-
A CDMO partner that steps up where others turn away
Expertise across oral, nasal, pulmonary and parenteral dosage forms
-
-
-
Case studies
Rapid tech transfer to clinical manufacture
Read how we reached clinical dosing within three months, through strong communication, flexibility and responsiveness.
Read the case study →
-
- About us
-
-
About Upperton
-
-
-
Working here
Scientists, not a form queue.
Open roles across formulation, analytical and operations.
See open roles →
-
- Resources
-
-
One library. Filter it your way.
Search across everything, then narrow by route, platform, service or stage.
Popular filters
- Spray drying
- Inhalation
- Biologics
- Solubility
- Phase I-II
- Sterile fill-finish
-
Browse by type
- Articles & InsightsTechnical articles from our scientists
- Whitepapers & InfosheetsIn-depth technical documents
- BrochuresCapability and facility overviews
- Webinars & Scientific PostersRecorded sessions and conference posters
- Media / Press KitLogos, imagery and press contacts
- FAQCommon questions on process and supply
-
Featured whitepaper
Spray drying biologics: an alternative to freeze drying.
Dr Richard Johnson, Chief Scientific Officer.
Download →
-
-
- Contact
-
-
One enquiry form. Tell us the stage and it routes itself.
No separate proposal request, no separate discovery call booking.
What stage is your project?
- Early / exploratory
- Pre-clinical
- Phase I-II
- Phase III+
- Commercial
Get in touch
Call +44 (0) 115 855 7050
Email contact@upperton.com
Visit Trent Gateway, Technology Drive, Beeston, Nottingham, NG9 1LA
-
Start a project
Send us the brief and we will reply within one working day.
Answered by a scientist who works on your route.
Open the form →
-
-